What Role Does Plasmapheresis Play in Modern Medicine as the Market Reaches $2.55 Billion by 2030?


Posted October 16, 2024 by Pratiksha

The forecast for the Plasmapheresis Market indicates it will reach $2.55 billion by 2030, with an expected CAGR of 8.6% from 2023 through 2030.
 
Meticulous Research®, a leading market research organization, has unveiled its latest report titled "Plasmapheresis Market by Product (Instruments, Disposables), Technology (Membrane Filtration, Centrifugation), Application (Therapeutic [Immunology, Neurology, Hematology], Plasma Collection), End User (Biopharma, Hospitals) - Global Forecast to 2030."

Request For Sample Report: https://www.meticulousresearch.com/request-sample-report/cp_id=3092?

The findings indicate that the plasmapheresis market is set to reach approximately $2.55 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.6% from 2023 to 2030. The growth trajectory of this market is driven by an escalating incidence of autoimmune diseases, heightened demand for source plasma from biopharmaceutical firms, and favorable reimbursement policies for plasmapheresis procedures. Furthermore, the increasing demand for plasmapheresis in emerging economies is anticipated to create notable growth opportunities.

However, the high costs linked to plasmapheresis devices and procedures, as well as the risks associated with the procedures themselves, are projected to restrain market growth. Additionally, challenges such as a lack of awareness regarding plasmapheresis procedures and limited access to these services in specific regions present significant barriers to market expansion.

Plasmapheresis Market: Looking Ahead
The plasmapheresis market is segmented based on product, technology, application, end user, and geography. The study also includes an analysis of key competitors and evaluates market dynamics at the country and regional levels.
From a product perspective, the disposables segment is expected to dominate the market share in 2023. This trend is largely due to the ongoing requirement for plasma separation filters and administration sets used in plasmapheresis procedures.
In terms of technology, the centrifugation segment is projected to capture the largest share of the market in 2023, owing to its efficiency in rapidly separating plasma from other blood components.

Regarding applications, the source plasma collection segment is anticipated to hold the largest market share in 2023. This growth is driven by the increasing demand for source plasma from pharmaceutical and biotechnology companies and a rising awareness of voluntary plasma donation initiatives.
From the end-user perspective, the source plasma collection segment is expected to account for the largest share in 2023, attributed to the growing need for source plasma for producing plasma-derived products using fractionation techniques.

Regional Market Analysis
This report analyzes the plasmapheresis market across several key regions, including North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, Switzerland, and other European countries), Asia-Pacific (Japan, China, India, Australia, and other Asia-Pacific nations), Latin America, and the Middle East & Africa.
In 2023, North America is expected to lead the plasmapheresis market, followed by Europe and Asia-Pacific. The strong market share in North America can be attributed to the increased awareness of plasmapheresis’ therapeutic benefits, a high prevalence of autoimmune diseases, rapid technological advancements, and a robust healthcare system.

Major Players in the Industry
Key companies in the plasmapheresis market include Asahi Kasei Corporation (Japan), Terumo Corporation (Japan), Baxter International Inc. (U.S.), B. Braun Melsungen AG (Germany), SB-Kawasumi Laboratories, Inc. (Japan), Kaneka Corporation (Japan), Haemonetics Corporation (U.S.), Fresenius SE & Co. KGaA (Germany), Shanghai Dahua Medical Apparatus Co., Ltd. (China), and Infomed SA (Switzerland).

Buy Now: https://www.meticulousresearch.com/Checkout/79432394?

About Meticulous Research®
Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.

Contact Us:
Meticulous Research®
Email- [email protected]
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Meticulous Research
Phone 07447780008
Business Address Office No-202, 203,204,205,206; 2nd Floor, Pushpak Business Hub, Pune, Wakad, Pimpri-Chinchwad, Maharashtra 411057
Country India
Categories Health , Medical , Research
Last Updated October 16, 2024